1Healey EA, Cook EF, Oran E J, et al. Contralateral breast cancer: Clinical characteristics and impact on prognosis[J]. J Clin Oncol, 1993,11 (8) :1545.
2Awad AT, el-Husseini G, Anwar M, et al. Bilateral primary breast cancers: a clinicopathological study of the second primary[J]. Int Surg,1996,81( 1 ) :57.
3Mose S, Adanietz IA ,Thilmann C, et al. Bilateral breast carcinoma versus unilateral disease: review of 498 patients[J]. Am J Clin Oncol, 1997,20 (6) :541.
3[1]Awad AT,el-Husseini,Anwar M,et al.Bilateral primary breast cancer:a clinicopathological study of the second primary[J].Int Surg,1996,81(1):57-60.
4[2]Kinoshita,Veda M,Enomoto K,et al.Comparison of p53 gene abnormalities in bilateral and unilateral breast cancer[J].Cancer,1995,76(12):2504-2509.
5[3]Rutguist LE,Cedermark B,Glas U,et al.Contralateral primary tumor in breast cancer patients in a randomized trial of adjuvant Tamoxifen therapy[J].J Natl Cancer Inst,1991,83(18):1299-1306.
6Pressman PI.Selective biopsy ofthopposite breast cancer[J].cancer, 1986;57(3):577.
7Fracchia, Robinsol,Legaspi, Survival in bilateral breast cancer[J].cancer, 1985;55(6):1414.
8左文树等主编.现代肿瘤学.济南:山东医科大学出版社,1996:512.
9Lee VW, Sax EJ, M cAneng D B, et al. A complementary rdefor thallium-201 scintigraphy with mammography in the diagnosis of breast cancer [J]. nuclMed, 1993,34(2) :2095.
10Moroz C,Kahn M,Chaimof C,et al. Ferritin-bearing lymphocytes in thediagnosis of breast cancer[ J]. cancer, 1984,54(1) :84.
